Nutraceutical Excipients Market by Product Source (Organic Chemicals, Inorganic Chemicals), Functionality (Binders, Colorants, Flavors & Sweeteners), End Product, Formulation, Functionality Application and Region - Global Forecast to 2028

January 2024 | 379 pages | ID: N7E9A0764FBEN
MarketsandMarkets

Abstracts

The global market for nutraceutical excipients is estimated at USD 4.2 billion in 2023 and is projected to reach USD 6.1 billion by 2028, at a CAGR of 7.7% during the forecast period. Customization of nutraceutical excipients is on the rise, meeting unique formulation needs. Companies are innovating, creating excipients suited for varied applications, enabling manufacturers to craft tailored nutraceuticals for diverse consumer requirements. Continuous advancements in excipient technologies are facilitating the development of specialized excipients, sought after for specific functionalities. The market demand focuses on excipients with enhanced solubility, improved taste-masking, controlled release, and superior absorption rates, fueling market expansion.

“The growing trend of personalization will propel the nutraceutical excipients market forward.”

The nutraceutical market is witnessing a surge in the trend of personalization, wherein consumers increasingly seek tailored products aligning with their individual health needs and preferences. This growing inclination towards personalized nutraceuticals has spurred a demand for customized excipients capable of adapting to specific formulations. These tailored excipients are pivotal in allowing formulators to create versatile supplements or functional foods, offering flexibility in dosage, release mechanisms, and targeted nutrient delivery. They enable the development of products precisely tailored to address unique health concerns or align with the preferences of consumers, thereby elevating the effectiveness and attractiveness of the final product. This evolution towards personalization underscores the importance of customized health solutions in the nutraceutical industry, reflecting the desire for individualized wellness approaches among discerning consumers.

“In 2022, binders stood as the second-largest segment within the by functionality of nutraceutical excipients. “

The segment of binders in the functionality category of nutraceutical excipients emerges as the second largest due to its pivotal role in controlling the tablet's dissolution properties. This control influences how the tablet disperses and delivers active ingredients within the digestive system, directly impacting the bioavailability and efficacy of the nutraceutical product. Binders' versatile nature in formulations allows for crafting tablets with varying release profiles, be it immediate or sustained release, accommodating a diverse range of active ingredients. Additionally, binders significantly contribute to tablet stability, preventing premature disintegration or breakage, thereby ensuring the tablet's structural integrity, a critical factor influencing its shelf life and effectiveness.

“Within the functionality application segment, modified-release segment holds the most substantial share.”

The leading position of modified-release excipients in the functionality application segment of the nutraceutical excipients market is attributed to their ability to intricately regulate the release of active ingredients within nutraceutical formulations. This control facilitates customized release profiles, encompassing sustained, delayed, or targeted release, thereby ensuring a controlled and consistent nutrient delivery in the body. Furthermore, these excipients optimize the bioavailability of nutrients by orchestrating a controlled and efficient release of active ingredients, ultimately enhancing the body's absorption and utilization of nutrients. Their role in facilitating a sustained and steady release of active ingredients significantly contributes to bolstering the effectiveness of nutraceuticals. This sustained delivery maintains optimal nutrient levels in the body, promoting superior health outcomes and solidifying their position as the foremost segment within the functionality application category of nutraceutical excipients.

“The nutraceutical excipients market in Europe is anticipated to maintain consistent growth throughout the forecast period.”

Growing health consciousness among Europeans is driving an escalating demand for functional foods and dietary supplements offering precise health advantages. With a substantial portion of the European population aged over 50, prone to chronic ailments, there's an increased inclination towards nutraceuticals for both preventive and therapeutic purposes. Ongoing advancements in research and development efforts are resulting in the emergence of innovative excipients characterized by improved functionality, enhanced bioavailability, and targeted nutrient delivery. These advancements are amplifying the effectiveness and attractiveness of nutraceuticals to consumers. Moreover, the surge in the personalization trend within the nutraceutical market is intensifying. Consumers are actively seeking tailored products aligned with their specific needs and preferences, prompting a heightened demand for customizable excipients adaptable to distinct formulations.

The Break-up of Primaries:

By Value Chain: Manufacturers – 80%, Suppliers – 20%

By Designation: CXOs – 44%, Managers – 34%, Executives – 22%

By Region: North America – 35%, Europe – 30%, APAC – 20%, South America – 10%, RoW - 5%

Research Coverage:

The report segments the nutraceutical excipients market based on formulation, functionality, functionality application, product source, end product, and region. In terms of insights, this report has focused on various levels of analyses—the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the nutraceutical excipients market, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. new product launches, mergers and acquisitions, and recent developments associated with the nutraceutical excipients market. Competitive analysis of upcoming startups in the nutraceutical excipients market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall nutraceutical excipients market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights on the following pointers:

• Analysis of key drivers (Increased focus on preventive care is encouraging investments in products/solutions, which, in turn, is driving the demand for nutraceutical excipients, advancements in nanotechnology equipped with new features to drive the growth of the nutraceutical excipients market, rise in demand for fortified food products due to the increase in health consciousness among consumers, and introduction of mandates on food fortification by government organizations), restraints (Decrease in returns on R&D investments and high costs of clinical trials and registration) opportunities (High use of excipients with multifunctional properties is witnessed as an emerging trend among key players), and challenges (Consumer skepticism associated with nutraceutical products due to rural and semi-urban consumer perception on dietary supplements as pharmaceutical drugs and their false claims).
• Product Development/Innovation: Detailed insights on, research & development activities, and new product launches in the nutraceutical excipients market
• Market Development: Comprehensive information about lucrative markets – the report analyses the nutraceutical excipients market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the nutraceutical excipients market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like International Flavors & Fragrances Inc (US), Kerry Group plc (Ireland), Ingredion (US), Sensient Technologies Corporation (US), Associated British Foods plc (UK), BASF SE (Germany), Roquette Fr?res (France), MEGGLE GmbH & Co. KG (Germany), Cargill, Incorporated (US), Ashland (US), IMCD (Netherlands), Hilmar Cheese Company, Inc (US), Air Liquide (France), Azelis Group (Luxembourg), Biogrund GmbH (Germany), Innophos (US), JRS PHARMA (Germany), Omya AG (Switzerland), Daicel Corporation (Japan), Alsiano A/S (Denmark), Colorcon (US), Fuji Chemical Industries Co., Ltd (Japan), Jigs Chemical (India), Panchamrut Chemicals (India), and GATTEFOSSE (France) among others in the nutraceutical excipients market.

Contents

1 INTRODUCTION

1.1 STUDY OBJECTIVES
  1.1.1 MARKET DEFINITION
1.2 MARKET SCOPE
  1.2.1 MARKET SEGMENTATION
FIGURE 1 NUTRACEUTICAL EXCIPIENTS MARKET SEGMENTATION
  1.2.2 INCLUSIONS & EXCLUSIONS
TABLE 1 NUTRACEUTICAL EXCIPIENTS MARKET: INCLUSIONS & EXCLUSIONS
  1.2.3 REGIONS COVERED
1.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
TABLE 2 USD EXCHANGE RATES CONSIDERED, 2019–2022
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
  1.6.1 RECESSION IMPACT ANALYSIS

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
FIGURE 2 NUTRACEUTICAL EXCIPIENTS MARKET: RESEARCH DESIGN
  2.1.1 SECONDARY DATA
    2.1.1.1 Key data from secondary sources
  2.1.2 PRIMARY DATA
    2.1.2.1 Key data from primary sources
    2.1.2.2 Key insights from industry experts
    2.1.2.3 Breakdown of primary profiles
2.2 MARKET SIZE ESTIMATION
FIGURE 3 BOTTOM-UP APPROACH
FIGURE 4 TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
FIGURE 5 DATA TRIANGULATION AND MARKET BREAKUP
2.4 ASSUMPTIONS
2.5 RESEARCH LIMITATIONS & ASSOCIATED RISKS
2.6 RECESSION IMPACT ANALYSIS
2.7 RECESSION MACRO-INDICATORS
FIGURE 6 RECESSION MACRO-INDICATORS
FIGURE 7 GLOBAL INFLATION RATE, 2011–2022
FIGURE 8 GLOBAL GDP, 2011–2022 (USD TRILLION)
FIGURE 9 RECESSION INDICATORS AND THEIR IMPACT ON NUTRACEUTICAL EXCIPIENTS MARKET
FIGURE 10 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET: EARLIER FORECAST VS. RECESSION FORECAST

3 EXECUTIVE SUMMARY

TABLE 3 NUTRACEUTICAL EXCIPIENTS MARKET SNAPSHOT, 2023 VS. 2028
FIGURE 11 NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023 VS. 2028 (USD MILLION)
FIGURE 12 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 13 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023 VS. 2028 (USD MILLION)
FIGURE 14 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023 VS. 2028 (USD MILLION)
FIGURE 15 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 16 NUTRACEUTICAL EXCIPIENTS MARKET: REGIONAL SNAPSHOT

4 PREMIUM INSIGHTS

4.1 BRIEF OVERVIEW OF NUTRACEUTICAL EXCIPIENTS MARKET
FIGURE 17 HEALTH-CONSCIOUS CONSUMERS, PREVENTIVE HEALTHCARE, AND PERSONALIZED NUTRITION TRENDS TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY AND KEY COUNTRY
FIGURE 18 COATING AGENTS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN NUTRACEUTICAL EXCIPIENTS MARKET IN 2022
4.3 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION
FIGURE 19 NORTH AMERICA TO DOMINATE NUTRACEUTICAL EXCIPIENTS MARKET FROM 2023 TO 2028 (USD MILLION)
4.4 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION
FIGURE 20 DRY SEGMENT ESTIMATED TO BE LARGEST THROUGHOUT FORECAST PERIOD (USD MILLION)
4.5 NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE
FIGURE 21 ORGANIC CHEMICALS TO BE LARGEST SEGMENT DURING FORECAST PERIOD (USD MILLION)
4.6 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION
FIGURE 22 MODIFIED RELEASE TO HOLD LARGEST SHARE IN NUTRACEUTICAL EXCIPIENTS MARKET DURING FORECAST PERIOD (USD MILLION)
4.7 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT
FIGURE 23 PROBIOTICS TO BE LARGEST SEGMENT DURING FORECAST PERIOD (USD MILLION)
FIGURE 24 CHINA, INDIA, AND SOUTH KOREA TO GROW AT HIGH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MACROECONOMIC INDICATORS
  5.2.1 GLOBAL POPULATION WITNESSING HIGH PREVALENCE OF OBESITY
  5.2.2 AGING POPULATION BECOMING MORE AWARE OF BENEFITS OF NUTRACEUTICALS
FIGURE 25 US POPULATION AGED 65 AND OLDER, 2000–2060 (MILLION)
5.3 MARKET DYNAMICS
FIGURE 26 NUTRACEUTICAL EXCIPIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  5.3.1 DRIVERS
    5.3.1.1 Increased focus on preventive care to encourage investments in products/solutions
FIGURE 27 NUMBER OF AMERICANS WITH CHRONIC CONDITIONS
    5.3.1.2 Advancements in nanotechnology equipped with new features relating to nutraceutical excipients
    5.3.1.3 Rise in demand for fortified food products due to increased health consciousness
    5.3.1.4 Mandates on food fortification by government organizations
TABLE 4 PREVALENCE OF THREE MAJOR MICRONUTRIENT DEFICIENCIES, BY REGION
  5.3.2 RESTRAINTS
    5.3.2.1 Decrease in returns on R&D investments and high costs of clinical trials and registration
  5.3.3 OPPORTUNITIES
    5.3.3.1 Multi-functionalities of excipients aiding in saving costs and processing time
    5.3.3.2 Rising awareness of micronutrient deficiencies
  5.3.4 CHALLENGES
    5.3.4.1 Consumer skepticism associated with nutraceutical products due to rural and semi-urban consumers' perception of dietary supplements as pharmaceutical drugs

6 INDUSTRY TRENDS

6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
FIGURE 28 NUTRACEUTICAL EXCIPIENTS MARKET: VALUE CHAIN ANALYSIS
  6.2.1 SOURCING OF RAW MATERIALS
  6.2.2 MANUFACTURING
  6.2.3 DISTRIBUTION, MARKETING, AND SALES
6.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
FIGURE 29 REVENUE SHIFT FOR NUTRACEUTICAL EXCIPIENTS MARKET
6.4 TECHNOLOGY ANALYSIS
  6.4.1 FOOD MICROENCAPSULATION
    6.4.1.1 Encapsulation of omega-3 to mask odor
  6.4.2 INNOVATIVE AND DISRUPTIVE TECH
    6.4.2.1 Robotics as key technological trend to lead to innovations
    6.4.2.2 3D printing to uplift future of nutraceutical excipients market with high-end products
6.5 PRICING ANALYSIS
FIGURE 30 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT, 2019–2022 (USD/TON)
TABLE 5 NORTH AMERICA: AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT, 2018–2022 (USD/TON)
TABLE 6 EUROPE: AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT, 2018–2022 (USD/TON)
TABLE 7 ASIA PACIFIC: AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT, 2018–2022 (USD/TON)
TABLE 8 SOUTH AMERICA: AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT, 2018–2022 (USD/TON)
TABLE 9 ROW: AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT, 2018–2022 (USD/TON)
6.6 PATENT ANALYSIS
FIGURE 31 LIST OF MAJOR PATENTS GRANTED FOR NUTRACEUTICAL EXCIPIENTS
FIGURE 32 REGIONAL ANALYSIS OF PATENTS GRANTED FOR NUTRACEUTICAL EXCIPIENTS MARKET, 2012–2022
  6.6.1 LIST OF MAJOR PATENTS
6.7 ECOSYSTEM/MARKET MAP
  6.7.1 UPSTREAM
    6.7.1.1 Excipient Manufacturers
    6.7.1.2 Technology Providers
  6.7.2 DOWNSTREAM
    6.7.2.1 Regulatory Bodies
    6.7.2.2 Nutraceutical Manufacturers
FIGURE 33 NUTRACEUTICAL EXCIPIENTS MARKET: ECOSYSTEM
TABLE 10 NUTRACEUTICAL EXCIPIENTS MARKET: ECOSYSTEM
6.8 TRADE SCENARIO
TABLE 11 IMPORT DATA OF VITAMINS FOR KEY COUNTRIES, 2022 (VALUE & VOLUME)
TABLE 12 EXPORT DATA OF VITAMINS FOR KEY COUNTRIES, 2022 (VALUE & VOLUME)
TABLE 13 IMPORT DATA OF AMINO ACIDS FOR KEY COUNTRIES, 2022 (VALUE & VOLUME)
TABLE 14 EXPORT DATA OF AMINO ACIDS FOR KEY COUNTRIES, 2022 (VALUE & VOLUME)
6.9 KEY CONFERENCES & EVENTS, 2023–2024
TABLE 15 NUTRACEUTICAL EXCIPIENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2023–2024
6.10 TARIFF AND REGULATORY LANDSCAPE
  6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  6.10.2 REGULATORY FRAMEWORK
    6.10.2.1 ORGANIZATIONS/REGULATIONS GOVERNING NUTRACEUTICAL EXCIPIENTS MARKET
TABLE 21 DEFINITIONS & REGULATIONS FOR NUTRACEUTICAL EXCIPIENTS WORLDWIDE
    6.10.2.2 North America
      6.10.2.2.1 Canada
      6.10.2.2.2 US
      6.10.2.2.3 Mexico
    6.10.2.3 European Union (EU)
    6.10.2.4 Asia Pacific
      6.10.2.4.1 Japan
      6.10.2.4.2 China
      6.10.2.4.3 India
      6.10.2.4.4 Australia & New Zealand
    6.10.2.5 Rest of the World (RoW)
      6.10.2.5.1 Israel
      6.10.2.5.2 Brazil
    6.10.2.6 Probiotics
      6.10.2.6.1 Introduction
      6.10.2.6.2 National/International bodies for safety standards and regulations
TABLE 22 DEFINITIONS & REGULATIONS FOR NUTRACEUTICALS WORLDWIDE
      6.10.2.6.3 Codex alimentarius commission (CAC)
      6.10.2.6.4 North America: regulatory environment analysis
        6.10.2.6.4.1 US
        6.10.2.6.4.2 Canada
      6.10.2.6.5 Asia Pacific: Regulatory environment analysis
        6.10.2.6.5.1 Japan
        6.10.2.6.5.2 India
      6.10.2.6.6 South America: Regulatory Environment Analysis
        6.10.2.6.6.1 Brazil
    6.10.2.7 PREBIOTICS
      6.10.2.7.1 Introduction
      6.10.2.7.2 Asia Pacific
        6.10.2.7.2.1 Japan
        6.10.2.7.2.2 Australia & New Zealand
        6.10.2.7.2.3 South Korea
        6.10.2.7.2.4 India
TABLE 23 SCHEDULE – XI OF FOOD SAFETY AND STANDARDS REGULATIONS, 2015, FOR LIST OF APPROVED PREBIOTIC EXCIPIENTS
      6.10.2.7.3 North America
        6.10.2.7.3.1 US
        6.10.2.7.3.2 Canada
TABLE 24 LIST OF ACCEPTED DIETARY FIBERS BY CANADIAN REGULATORY AUTHORITIES & THEIR SOURCES
      6.10.2.7.4 European Union
6.11 PORTER’S FIVE FORCES ANALYSIS
TABLE 25 PORTER’S FIVE FORCES IMPACT ON NUTRACEUTICAL EXCIPIENTS MARKET
  6.11.1 INTENSITY OF COMPETITIVE RIVALRY
  6.11.2 BARGAINING POWER OF SUPPLIERS
  6.11.3 BARGAINING POWER OF BUYERS
  6.11.4 THREAT OF SUBSTITUTES
  6.11.5 THREAT OF NEW ENTRANTS
6.12 KEY STAKEHOLDERS AND BUYING CRITERIA
  6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 TYPES
TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 PRODUCT SOURCES (%)
  6.12.2 BUYING CRITERIA
TABLE 27 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR FOR TOP 3 TYPES
FIGURE 35 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR FOR TOP 3 TYPES
6.13 CASE STUDY ANALYSIS
  6.13.1 USE CASE 1: FRUNUTTA STARTED OFFERING EASY-TO-USE AND EFFICIENT-TO-TAKE VITAMIN AND MINERAL PILLS THAT DISSOLVE INSTANTLY
  6.13.2 USE CASE 2: EXCIPIENTS OF CHOICE FOR TASTE MASKING TECHNOLOGY WITH HOT MELT EXTRUSION

7 NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE

7.1 INTRODUCTION
FIGURE 36 NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023 VS. 2028 (USD MILLION)
7.2 ORGANIC CHEMICALS
TABLE 28 ORGANIC EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 29 ORGANIC EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
TABLE 30 ORGANIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 31 ORGANIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2023–2028 (USD MILLION)
  7.2.1 OLEOCHEMICALS
TABLE 32 OLEOCHEMICALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2018–2022 (USD MILLION)
TABLE 33 OLEOCHEMICALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2023–2028 (USD MILLION)
    7.2.1.1 Fatty alcohols
      7.2.1.1.1 Need for enhancing texture and creaminess likely to propel demand
    7.2.1.2 Mineral stearates
      7.2.1.2.1 Mineral stearates to reduce friction and avoid equipment clogging during manufacturing of nutraceuticals
    7.2.1.3 Glycerin
      7.2.1.3.1 Glycerin to help improve smoothness and lubrication process
    7.2.1.4 Other oleochemicals
  7.2.2 CARBOHYDRATES
TABLE 34 CARBOHYDRATES: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2018–2022 (USD MILLION)
TABLE 35 CARBOHYDRATES: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2023–2028 (USD MILLION)
    7.2.2.1 Sugars
TABLE 36 SUGARS: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2018–2022 (USD MILLION)
TABLE 37 SUGARS: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2023–2028 (USD MILLION)
      7.2.2.1.1 Actual sugars
        7.2.2.1.1.1 Rising diabetic population to fuel need for low-glycemic index alternatives like xylitol and isomaltulose
      7.2.2.1.2 Sugar alcohols
        7.2.2.1.2.1 Various advantageous and unique properties of sugar alcohols to make them attractive option
      7.2.2.1.3 Artificial sweeteners
        7.2.2.1.3.1 Emerging trends in utilization of natural sweeteners in nutraceutical products to drive demand
    7.2.2.2 Cellulose
TABLE 38 CELLULOSE: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2018–2022 (USD MILLION)
TABLE 39 CELLULOSE: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2023–2028 (USD MILLION)
      7.2.2.2.1 Microcrystalline cellulose
        7.2.2.2.1.1 Rising nutraceutical trend to bolster microcrystalline cellulose demand for superior tablet integrity
      7.2.2.2.2 Cellulose ethers
        7.2.2.2.2.1 Cellulose ethers help streamline nutraceutical rheology
      7.2.2.2.3 CMC & croscarmellose sodium
        7.2.2.2.3.1 Enhanced mouthfeel and fast-acting properties to help propel market growth
      7.2.2.2.4 Cellulose esters
        7.2.2.2.4.1 Rising demand for cellulose esters to provide technical edge in nutraceuticals
    7.2.2.3 Starch
TABLE 40 STARCH: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2018–2022 (USD MILLION)
TABLE 41 STARCH: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2023–2028 (USD MILLION)
      7.2.2.3.1 Modified starch
        7.2.2.3.1.1 Technical advancements to fuel modified starch demand in nutraceuticals excipients industry
      7.2.2.3.2 Dried starch
        7.2.2.3.2.1 Capabilities such as disintegration enhancement and bulking effects to drive market
      7.2.2.3.3 Converted starch
        7.2.2.3.3.1 Properties such as increased solubility to boost nutrient absorption
  7.2.3 PETROCHEMICALS
TABLE 42 PETROCHEMICALS EXCIPIENTS MARKET, BY, SUBTYPE, 2018–2022 (USD MILLION)
TABLE 43 PETROCHEMICALS EXCIPIENTS MARKET, BY SUBTYPE, 2023–2028 (USD MILLION)
    7.2.3.1 Glycols
      7.2.3.1.1 Humectant & solvent properties to drive demand
    7.2.3.2 Povidones
      7.2.3.2.1 Film-forming function to provide controlled release of active ingredients
    7.2.3.3 Mineral hydrocarbons
      7.2.3.3.1 Properties such as anti-foaming & lubrication to help in nutraceutical manufacturing
    7.2.3.4 Acrylic polymers
      7.2.3.4.1 Diverse functions of acrylic polymers in nutraceuticals to propel growth
    7.2.3.5 Other petrochemical excipients
  7.2.4 PROTEINS
    7.2.4.1 Expanding utilization of proteins as carriers for microparticles and nanoparticles to propel market growth
  7.2.5 OTHER ORGANIC CHEMICALS
7.3 INORGANIC CHEMICALS
TABLE 44 INORGANIC EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 45 INORGANIC EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
TABLE 46 INORGANIC CHEMICALS EXCIPIENTS MARKET, BY SUBTYPE, 2018–2022 (USD MILLION)
TABLE 47 INORGANIC CHEMICALS EXCIPIENTS MARKET, BY SUBTYPE, 2023–2028 (USD MILLION)
  7.3.1 CALCIUM PHOSPHATE
    7.3.1.1 Nutraceutical production to be optimized by utilizing GMO-free calcium phosphates as GRAS excipients
  7.3.2 METAL OXIDES
    7.3.2.1 Metal oxides to help meet rising demand for iron-enriched nutraceuticals
  7.3.3 HALITES
    7.3.3.1 Halites to ensure taste improvement and salting-out techniques
  7.3.4 CALCIUM CARBONATE
    7.3.4.1 Focus on R&D of calcium carbonate to help launch new products
  7.3.5 CALCIUM SULFATE
    7.3.5.1 Improved flowability to drive demand for calcium sulfate
  7.3.6 OTHER INORGANIC CHEMICALS
7.4 OTHER CHEMICALS
TABLE 48 OTHER CHEMICALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 49 OTHER CHEMICALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)

8 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT

8.1 INTRODUCTION
TABLE 50 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018–2022 (USD MILLION)
TABLE 51 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023–2028 (USD MILLION)
FIGURE 37 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023 VS. 2028
8.2 PROBIOTICS
  8.2.1 INCREASING INCLINATION OF CONSUMERS TOWARD IMMUNITY-ENHANCING PRODUCTS POST-COVID-19 TO DRIVE MARKET GROWTH
TABLE 52 PROBIOTICS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 53 PROBIOTICS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
8.3 PREBIOTICS
  8.3.1 INCREASE IN DIGESTIVE ISSUES AMONG CONSUMERS RESULTING IN ACIDITY AND INFLAMMATORY ISSUES, TO ENCOURAGE CONSUMPTION OF PREBIOTICS AS PREVENTIVE MEASURE
TABLE 54 PREBIOTICS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 55 PREBIOTICS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
8.4 PROTEINS & AMINO ACIDS
  8.4.1 INCREASED POPULARITY OF PROTEINS AND AMINO ACIDS AMONG YOUTH TO DRIVE GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET
TABLE 56 PROTEINS & AMINO ACIDS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 57 PROTEINS & AMINO ACIDS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
8.5 VITAMINS
  8.5.1 PREVALENCE OF VITAMIN DEFICIENCIES AMONG CONSUMERS TO DRIVE MARKET GROWTH FOR NUTRACEUTICAL EXCIPIENTS
TABLE 58 VITAMINS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 59 VITAMINS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
TABLE 60 LIST OF NUTRIENTS AND THEIR RELEVANCE
8.6 MINERALS
  8.6.1 BENEFITS OFFERED FOR OPTIMAL FUNCTIONING OF BRAIN AND HEART TO DRIVE GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET
TABLE 61 MINERALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 62 MINERALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
8.7 OMEGA-3 FATTY ACIDS
  8.7.1 INCREASE IN HEART DISEASES TO DRIVE DEMAND FOR OMEGA-3 FATTY ACIDS SUPPLEMENTS
TABLE 63 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 64 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
8.8 OTHER END PRODUCTS
TABLE 65 OTHER END PRODUCTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 66 OTHER END PRODUCTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)

9 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION

9.1 INTRODUCTION
TABLE 67 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2018–2022 (USD MILLION)
TABLE 68 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2028 (USD MILLION)
FIGURE 38 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023 VS. 2028
9.2 DRY
TABLE 69 DRY: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 70 DRY: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
  9.2.1 TABLETS
    9.2.1.1 Easy to carry and portable nature to make them attractive option
  9.2.2 CAPSULES
    9.2.2.1 Quick-dissolving capsule shells for targeted absorption to be ideal for nutraceuticals designed to act in specific areas of digestive tract
9.3 LIQUID
  9.3.1 POTENTIAL GROWTH OPPORTUNITIES FOR LIQUID NUTRACEUTICAL EXCIPIENTS DUE TO INNOVATIONS IN FORMULATIONS TO DRIVE GROWTH
TABLE 71 LIQUID: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 72 LIQUID: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
9.4 OTHER FORMULATIONS
TABLE 73 OTHER FORMULATIONS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 74 OTHER FORMULATIONS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)

10 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY

10.1 INTRODUCTION
TABLE 75 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 76 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
FIGURE 39 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023 VS. 2028
10.2 BINDERS
  10.2.1 INCREASED ACCEPTABILITY AND USE OF BINDING AGENTS IN PRODUCTS TO DRIVE GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET
TABLE 77 BINDERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 78 BINDERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
10.3 FILLERS & DILUENTS
  10.3.1 USE OF ACTIVE INGREDIENTS IN NUTRACEUTICAL PRODUCTS TO ENCOURAGE USE OF FILLERS AND DILUENTS AS EXCIPIENTS
TABLE 79 FILLERS & DILUENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 80 FILLERS & DILUENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
10.4 DISINTEGRANTS
  10.4.1 HIGH CONSUMPTION OF DIETARY SUPPLEMENTS IN FORM OF ORAL DOSAGES OR TABLETS TO DRIVE GROWTH OF DISINTEGRANTS SEGMENT
TABLE 81 DISINTEGRANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 82 DISINTEGRANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
10.5 COATING AGENTS
  10.5.1 PROTECTION FROM MOISTURE AND BACTERIA TO DRIVE DEMAND
TABLE 83 COATING AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 84 COATING AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
10.6 FLAVORING AGENTS & SWEETENERS
  10.6.1 INCREASE IN NEED FOR MASKING STRONG AND UNAPPEALING FLAVORS TO DRIVE GROWTH OF SEGMENT
TABLE 85 FLAVORING AGENTS & SWEETENERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 86 FLAVORING AGENTS & SWEETENERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
10.7 PRESERVATIVES
  10.7.1 INHIBITION OF MICROBIAL GROWTH AND MAINTAINING PRODUCT QUALITY AND SAFETY TO DRIVE DEMAND FOR PRESERVATIVES
TABLE 87 PRESERVATIVES: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 88 PRESERVATIVES: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
10.8 LUBRICANTS & GLIDANTS
  10.8.1 INCREASE IN NEED FOR REDUCING FRICTION AND KEEPING FORMULATION INTACT DURING PRODUCTION PROCESS TO DRIVE GROWTH OF SEGMENT
TABLE 89 LUBRICANTS & GLIDANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 90 LUBRICANTS & GLIDANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
10.9 SUSPENDING & VISCOSITY AGENTS
  10.9.1 PREVENTING SETTLING TO HELP MAINTAIN HOMOGENEITY AND STABILITY OF PRODUCT
TABLE 91 SUSPENDING & VISCOSITY AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 92 SUSPENDING & VISCOSITY AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
10.10 COLORANTS
  10.10.1 NEED FOR VISUAL APPEAL AND PRODUCT DIFFERENTIATION TO FUEL DEMAND FOR COLORANTS
TABLE 93 COLORANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 94 COLORANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
10.11 EMULSIFYING AGENTS
  10.11.1 NEED FOR REDUCING SURFACE TENSION BETWEEN DIFFERENT COMPONENTS TO DRIVE DEMAND FOR EMULSIFYING AGENTS
TABLE 95 EMULSIFYING AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 96 EMULSIFYING AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
10.12 OTHER FUNCTIONALITIES
TABLE 97 OTHER FUNCTIONALITIES: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 98 OTHER FUNCTIONALITIES: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)

11 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION

11.1 INTRODUCTION
TABLE 99 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2018–2022 (USD MILLION)
TABLE 100 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATI0N, 2023–2028 (USD MILLION)
FIGURE 40 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023 VS. 2028
11.2 TASTE MASKING
  11.2.1 CREATING DIFFERENTIATION TO BE KEY IN THIS COMPETITIVE MARKET
TABLE 101 TASTE MASKING: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 102 TASTE MASKING: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
11.3 STABILIZERS
  11.3.1 MAINTAINING DESIRABLE PROPERTIES UNTIL CONSUMPTION TO DRIVE DEMAND FOR STABILIZERS
TABLE 103 STABILIZERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 104 STABILIZERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
11.4 MODIFIED RELEASE
  11.4.1 NEED FOR SLOWER AND STEADIER RELEASE OF COMPOUNDS TO PROPEL GROWTH OF MODIFIED-RELEASE APPLICATION IN NUTRACEUTICAL EXCIPIENTS MARKET
TABLE 105 MODIFIED RELEASE: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 106 MODIFIED RELEASE: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
11.5 SOLUBILITY & BIOAVAILABILITY ENHANCEMENT
  11.5.1 CHALLENGES RELATED TO POOR SOLUBILITY AND LIMITED ABSORPTION OF BIOACTIVE COMPOUNDS TO DRIVE DEMAND
TABLE 107 SOLUBILITY & BIOAVAILABILITY ENHANCEMENT: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 108 SOLUBILITY & BIOAVAILABILITY ENHANCEMENT: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
11.6 OTHER FUNCTIONALITY APPLICATIONS
TABLE 109 OTHER FUNCTIONALITY APPLICATIONS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 110 OTHER FUNCTIONALITY APPLICATIONS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)

12 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION

12.1 INTRODUCTION
FIGURE 41 NORTH AMERICA TO BE LARGEST MARKET THROUGHOUT FORECAST PERIOD
FIGURE 42 CHINA, INDIA, AND SOUTH KOREA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
TABLE 111 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 112 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
12.2 NORTH AMERICA
FIGURE 43 NORTH AMERICA: MARKET SNAPSHOT
  12.2.1 RECESSION IMPACT ANALYSIS
FIGURE 44 NORTH AMERICAN NUTRACEUTICAL EXCIPIENTS MARKET: RECESSION IMPACT ANALYSIS
TABLE 113 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 114 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 115 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2018–2022 (USD MILLION)
TABLE 116 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023–2028 (USD MILLION)
TABLE 117 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 118 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
TABLE 119 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2018–2022 (USD MILLION)
TABLE 120 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2028 (USD MILLION)
TABLE 121 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018–2022 (USD MILLION)
TABLE 122 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023–2028 (USD MILLION)
TABLE 123 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2018–2022 (USD MILLION)
TABLE 124 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2028 (USD MILLION)
  12.2.2 US
    12.2.2.1 High concentration of key players, various nutrition awareness programs, and increase in preventive healthcare trends in US
TABLE 125 US: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 126 US: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
  12.2.3 CANADA
    12.2.3.1 Demand for quality and cost-competition: Two key factors for manufacturers to consider in Canada
TABLE 127 CANADA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 128 CANADA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
  12.2.4 MEXICO
    12.2.4.1 Increase in foreign direct investments and rise in awareness regarding healthier lifestyles associated with dietary supplements
TABLE 129 MEXICO: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 130 MEXICO: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
12.3 EUROPE
  12.3.1 RECESSION IMPACT ANALYSIS
FIGURE 45 EUROPEAN NUTRACEUTICAL EXCIPIENTS MARKET: RECESSION IMPACT ANALYSIS
TABLE 131 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 132 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 133 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2018–2022 (USD MILLION)
TABLE 134 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023–2028 (USD MILLION)
TABLE 135 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 136 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
TABLE 137 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2018–2022 (USD MILLION)
TABLE 138 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2028 (USD MILLION)
TABLE 139 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018–2022 (USD MILLION)
TABLE 140 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023–2028 (USD MILLION)
TABLE 141 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2018–2022 (USD MILLION)
TABLE 142 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2028 (USD MILLION)
  12.3.2 GERMANY
    12.3.2.1 Demand for nutraceutical excipients likely to increase to serve health-conscious consumers
TABLE 143 GERMANY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 144 GERMANY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
  12.3.3 FRANCE
    12.3.3.1 Innovations in product formulations to cater to increased consumer demands
TABLE 145 FRANCE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 146 FRANCE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
  12.3.4 UK
    12.3.4.1 Growth of functional/fortified food & beverage industry in UK to drive demand for nutraceutical excipients
TABLE 147 UK: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 148 UK: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
  12.3.5 ITALY
    12.3.5.1 Growing trend of online OTC and food supplement purchases in Italy
TABLE 149 ITALY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 150 ITALY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
  12.3.6 SPAIN
    12.3.6.1 Growth of food supplements, sports nutrition, and healthcare care markets likely to create favorable environment for nutraceutical excipients
TABLE 151 SPAIN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 152 SPAIN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
  12.3.7 REST OF EUROPE
TABLE 153 REST OF EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 154 REST OF EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
12.4 ASIA PACIFIC
FIGURE 46 ASIA PACIFIC: MARKET SNAPSHOT
  12.4.1 RECESSION IMPACT ANALYSIS
FIGURE 47 ASIA PACIFIC NUTRACEUTICAL EXCIPIENTS MARKET: RECESSION IMPACT ANALYSIS
TABLE 155 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 156 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 157 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2018–2022 (USD MILLION)
TABLE 158 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023–2028 (USD MILLION)
TABLE 159 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 160 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
TABLE 161 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2018–2022 (USD MILLION)
TABLE 162 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2028 (USD MILLION)
TABLE 163 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018–2022 (USD MILLION)
TABLE 164 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023–2028 (USD MILLION)
TABLE 165 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2018–2022 (USD MILLION)
TABLE 166 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2028 (USD MILLION)
  12.4.2 CHINA
    12.4.2.1 Rise in preference for nutraceutical products and innovations in dietary supplement formulations and fortified food products
TABLE 167 CHINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 168 CHINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
  12.4.3 JAPAN
    12.4.3.1 Manufacturers should think beyond pills & innovation to tap this growing market in Japan
TABLE 169 JAPAN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 170 JAPAN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
  12.4.4 INDIA
    12.4.4.1 Government policies and importance of nutraceuticals in daily life
TABLE 171 INDIA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 172 INDIA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
  12.4.5 SOUTH KOREA
    12.4.5.1 Rapid growth of supplements industry in South Korea
TABLE 173 SOUTH KOREA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 174 SOUTH KOREA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
  12.4.6 REST OF ASIA PACIFIC
TABLE 175 REST OF ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 176 REST OF ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
12.5 SOUTH AMERICA
  12.5.1 RECESSION IMPACT ANALYSIS
FIGURE 48 SOUTH AMERICAN NUTRACEUTICAL EXCIPIENTS MARKET: RECESSION IMPACT ANALYSIS
TABLE 177 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 178 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 179 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2018–2022 (USD MILLION)
TABLE 180 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023–2028 (USD MILLION)
TABLE 181 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 182 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
TABLE 183 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2018–2022 (USD MILLION)
TABLE 184 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2028 (USD MILLION)
TABLE 185 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018–2022 (USD MILLION)
TABLE 186 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023–2028 (USD MILLION)
TABLE 187 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2018–2022 (USD MILLION)
TABLE 188 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2028 (USD MILLION)
  12.5.2 BRAZIL
    12.5.2.1 Growth in awareness regarding benefits of functional foods and rise in aging population in Brazil
TABLE 189 BRAZIL: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 190 BRAZIL: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
  12.5.3 ARGENTINA
    12.5.3.1 Country’s focus on prevention healthcare system to be positive sign for nutraceutical excipients market
TABLE 191 ARGENTINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 192 ARGENTINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
  12.5.4 REST OF SOUTH AMERICA
TABLE 193 REST OF SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 194 REST OF SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
12.6 REST OF THE WORLD (ROW)
  12.6.1 RECESSION IMPACT ANALYSIS
FIGURE 49 ROW NUTRACEUTICAL EXCIPIENTS MARKET: RECESSION IMPACT ANALYSIS
TABLE 195 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 196 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
TABLE 197 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2018–2022 (USD MILLION)
TABLE 198 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023–2028 (USD MILLION)
TABLE 199 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 200 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
TABLE 201 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2018–2022 (USD MILLION)
TABLE 202 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2028 (USD MILLION)
TABLE 203 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018–2022 (USD MILLION)
TABLE 204 ROW NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023–2028 (USD MILLION)
TABLE 205 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2018–2022 (USD MILLION)
TABLE 206 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2028 (USD MILLION)
  12.6.2 MIDDLE EAST
    12.6.2.1 Rise in obesity and other health-related concerns in Middle East
TABLE 207 MIDDLE EAST: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 208 MIDDLE EAST: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
  12.6.3 AFRICA
    12.6.3.1 Intra-African trade policies and investments by global nutraceutical players
TABLE 209 AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
TABLE 210 AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)

13 COMPETITIVE LANDSCAPE

13.1 OVERVIEW
13.2 MARKET SHARE ANALYSIS
TABLE 211 NUTRACEUTICAL EXCIPIENTS MARKET: DEGREE OF COMPETITION, 2022
13.3 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 212 STRATEGIES ADOPTED BY KEY PLAYERS
13.4 REVENUE ANALYSIS
FIGURE 50 HISTORICAL REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022 (USD BILLION)
13.5 KEY PLAYER ANNUAL REVENUE VS. GROWTH
FIGURE 51 ANNUAL REVENUE, 2022 (USD BILLION) VS. REVENUE GROWTH, 2020–2022 (%)
13.6 KEY PLAYERS’ EBIT/EBITDA
FIGURE 52 EBITDA, 2022 (USD BILLION)
13.7 GLOBAL SNAPSHOT OF KEY MARKET PARTICIPANTS
FIGURE 53 NUTRACEUTICAL EXCIPIENTS MARKET: GLOBAL SNAPSHOT OF KEY MARKET PARTICIPANTS, 2022
13.8 COMPANY EVALUATION MATRIX (KEY PLAYERS)
  13.8.1 STARS
  13.8.2 EMERGING LEADERS
  13.8.3 PERVASIVE PLAYERS
  13.8.4 PARTICIPANTS
FIGURE 54 COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
  13.8.5 COMPANY FOOTPRINT
TABLE 213 COMPANY FOOTPRINT, BY FUNCTIONALITY
TABLE 214 COMPANY FOOTPRINT, BY PRODUCT SOURCE
TABLE 215 COMPANY FOOTPRINT, BY REGION
TABLE 216 OVERALL COMPANY FOOTPRINT
13.9 STARTUP/SME EVALUATION MATRIX
  13.9.1 PROGRESSIVE COMPANIES
  13.9.2 RESPONSIVE COMPANIES
  13.9.3 DYNAMIC COMPANIES
  13.9.4 STARTING BLOCKS
FIGURE 55 STARTUP/SME EVALUATION MATRIX, 2022
  13.9.5 COMPETITIVE BENCHMARKING
TABLE 217 NUTRACEUTICAL EXCIPIENTS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 218 NUTRACEUTICAL EXCIPIENTS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
TABLE 219 COMPANY FOOTPRINT, BY FUNCTIONALITY (STARTUPS)
13.10 COMPETITIVE SCENARIO
  13.10.1 NEW PRODUCT LAUNCHES
TABLE 220 NUTRACEUTICAL EXCIPIENTS MARKET: NEW PRODUCT LAUNCHES, 2019–2023
  13.10.2 DEALS
TABLE 221 NUTRACEUTICAL EXCIPIENTS MARKET: DEALS, 2019–2023
  13.10.3 OTHERS
TABLE 222 NUTRACEUTICAL EXCIPIENTS MARKET: OTHERS, 2019–2023

14 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
14.1 KEY PLAYERS
  14.1.1 INTERNATIONAL FLAVORS & FRAGRANCES INC
TABLE 223 INTERNATIONAL FLAVORS & FRAGRANCES INC: BUSINESS OVERVIEW
FIGURE 56 INTERNATIONAL FLAVORS & FRAGRANCES INC: COMPANY SNAPSHOT
TABLE 224 INTERNATIONAL FLAVORS & FRAGRANCES INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 225 INTERNATIONAL FLAVORS & FRAGRANCES INC: PRODUCT LAUNCHES
TABLE 226 INTERNATIONAL FLAVORS & FRAGRANCES INC: DEALS
  14.1.2 KERRY GROUP PLC
TABLE 227 KERRY GROUP PLC: BUSINESS OVERVIEW
FIGURE 57 KERRY GROUP PLC: COMPANY SNAPSHOT
TABLE 228 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 229 KERRY GROUP PLC: DEALS
  14.1.3 INGREDION
TABLE 230 INGREDION: BUSINESS OVERVIEW
FIGURE 58 INGREDION: COMPANY SNAPSHOT
TABLE 231 INGREDION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 232 INGREDION: DEALS
  14.1.4 SENSIENT TECHNOLOGIES CORPORATION
TABLE 233 SENSIENT TECHNOLOGIES CORPORATION: BUSINESS OVERVIEW
FIGURE 59 SENSIENT TECHNOLOGIES CORPORATION: COMPANY SNAPSHOT
TABLE 234 SENSIENT TECHNOLOGIES CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 235 SENSIENT TECHNOLOGIES CORPORATION: DEALS
  14.1.5 ASSOCIATED BRITISH FOODS PLC
TABLE 236 ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW
FIGURE 60 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT
TABLE 237 ASSOCIATED BRITISH FOODS PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 238 ASSOCIATED BRITISH FOODS PLC: PRODUCT LAUNCHES
  14.1.6 BASF SE
TABLE 239 BASF SE: BUSINESS OVERVIEW
FIGURE 61 BASF SE: COMPANY SNAPSHOT
TABLE 240 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 241 BASF SE: DEALS
TABLE 242 BASF SE: OTHERS
  14.1.7 ROQUETTE FR?RES
TABLE 243 ROQUETTE FR?RES: BUSINESS OVERVIEW
TABLE 244 ROQUETTE FR?RES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 245 ROQUETTE FR?RES: PRODUCT LAUNCHES
TABLE 246 ROQUETTE FR?RES: DEALS
TABLE 247 ROQUETTE FR?RES: OTHERS
  14.1.8 MEGGLE GROUP GMBH
TABLE 248 MEGGLE GROUP GMBH: BUSINESS OVERVIEW
TABLE 249 MEGGLE GROUP GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  14.1.9 CARGILL, INCORPORATED
TABLE 250 CARGILL, INCORPORATED: BUSINESS OVERVIEW
FIGURE 62 CARGILL, INCORPORATED: COMPANY SNAPSHOT
TABLE 251 CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 252 CARGILL, INCORPORATED: DEALS
TABLE 253 CARGILL, INCORPORATED: OTHERS
  14.1.10 ASHLAND
TABLE 254 ASHLAND: BUSINESS OVERVIEW
FIGURE 63 ASHLAND: COMPANY SNAPSHOT
TABLE 255 ASHLAND: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 256 ASHLAND: PRODUCT LAUNCHES
TABLE 257 ASHLAND: OTHERS
  14.1.11 AZELIS GROUP
TABLE 258 AZELIS GROUP: BUSINESS OVERVIEW
FIGURE 64 AZELIS GROUP: COMPANY SNAPSHOT
TABLE 259 AZELIS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 260 AZELIS GROUP: DEALS
TABLE 261 AZELIS GROUP: OTHERS
  14.1.12 IMCD
TABLE 262 IMCD: BUSINESS OVERVIEW
FIGURE 65 IMCD: COMPANY SNAPSHOT
TABLE 263 IMCD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 264 IMCD: DEALS
TABLE 265 IMCD: OTHERS
  14.1.13 HILMAR CHEESE COMPANY, INC.
TABLE 266 HILMAR CHEESE COMPANY, INC: BUSINESS OVERVIEW
TABLE 267 HILMAR CHEESE COMPANY, INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  14.1.14 SEPPIC
TABLE 268 SEPPIC: BUSINESS OVERVIEW
TABLE 269 SEPPIC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 270 SEPPIC: PRODUCT LAUNCHES
  14.1.15 BIOGRUND GMBH
TABLE 271 BIOGRUND GMBH: BUSINESS OVERVIEW
TABLE 272 BIOGRUND GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
14.2 OTHER PLAYERS
  14.2.1 INNOPHOS
TABLE 273 INNOPHOS: BUSINESS OVERVIEW
TABLE 274 INNOPHOS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 275 INNOPHOS: PRODUCT LAUNCHES
  14.2.2 DAICEL CORPORATION
TABLE 276 DAICEL CORPORATION: BUSINESS OVERVIEW
FIGURE 66 DAICEL CORPORATION: COMPANY SNAPSHOT
TABLE 277 DAICEL CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  14.2.3 ALSIANO A/S
TABLE 278 ALSIANO A/S: BUSINESS OVERVIEW
TABLE 279 ALSIANO A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  14.2.4 JRS PHARMA
TABLE 280 JRS PHARMA: BUSINESS OVERVIEW
TABLE 281 JRS PHARMA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 282 JRS PHARMA: OTHERS
  14.2.5 COLORCON
TABLE 283 COLORCON: BUSINESS OVERVIEW
TABLE 284 COLORCON: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 285 COLORCON: PRODUCT LAUNCHES
TABLE 286 COLORCON: DEALS
TABLE 287 COLORCON: OTHERS
  14.2.6 PANCHAMRUT CHEMICALS
TABLE 288 PANCHAMRUT CHEMICALS: BUSINESS OVERVIEW
  14.2.7 OMYA
TABLE 289 OMYA: BUSINESS OVERVIEW
  14.2.8 GATTEFOSSЙ
TABLE 290 GATTEFOSSЙ: BUSINESS OVERVIEW
  14.2.9 FUJI CHEMICAL INDUSTRIES CO., LTD
TABLE 291 FUJI CHEMICAL INDUSTRIES CO., LTD: BUSINESS OVERVIEW
  14.2.10 JIGS CHEMICAL
TABLE 292 JIGS CHEMICAL: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.

15 ADJACENT & RELATED MARKETS

15.1 INTRODUCTION
15.2 LIMITATIONS
15.3 FUNCTIONAL FOOD INGREDIENTS MARKET
  15.3.1 MARKET DEFINITION
  15.3.2 MARKET OVERVIEW
  15.3.3 FUNCTIONAL FOOD INGREDIENTS MARKET, BY TYPE
    15.3.3.1 Introduction
TABLE 293 FUNCTIONAL FOOD INGREDIENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
TABLE 294 FUNCTIONAL FOOD INGREDIENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
15.4 NUTRACEUTICAL INGREDIENTS MARKET
  15.4.1 MARKET DEFINITION
  15.4.2 MARKET OVERVIEW
  15.4.3 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE
    15.4.3.1 Introduction
TABLE 295 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
TABLE 296 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
TABLE 297 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (KT)
TABLE 298 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (KT)

16 APPENDIX

16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS